Z5B-32005-21303
3 vaccinations
0 coded responses
15 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 016 / MA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
- 2020-12-27
- 2020-12-29
- 2020-12-30
- 2021-01-07
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-18
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-19
- 2021-02-25
- 2021-04-13
- 2022-01-12
-
2022-01-14
Dose 3 — Pfizer-BioNTech
- 2022-01-15
- 2022-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-18 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.